نویسندگان | ستاره عیسائی,زهره زهرایی,داوود پورسینا,محمد اسماعیل اکبری,حلاله واعظی هریس |
---|---|
نشریه | Molecular Biology Reports |
ضریب تاثیر (IF) | ثبت نشده |
نوع مقاله | Full Paper |
تاریخ انتشار | 2024-06-01 |
رتبه نشریه | علمی - پژوهشی |
نوع نشریه | الکترونیکی |
کشور محل چاپ | ایران |
نمایه نشریه | JCR |
چکیده مقاله
Background: Breast cancer is one of the most common diseases in females, arising from overexpression of a variety of oncogenes like HER2/neu. The amplification rate of this gene is variable in different breast cancer patients. In this study, the amplification of the HER2/neu oncogene was distinguished in breast cancer patients and its correlation with prognostic factors. Also, the simultaneous effect of prognostic factors on the occurrence of a specific prognostic factor was investigated. Materials and methods: The multiplex PCR technique was used to assay the amplification of the HER2/neu oncogene in breast cancer patients. After extracting DNA from 100 tumor tissue and 8 normal breast tissue samples, the amplification of the HER2/neu gene was distinguished by the co-amplification of a single-copy reference gene, γ-IFN, and the target gene HER2/neu in the PCR reaction and using the Gel analyzer software. SPSS 23 and STATA 9.1 software were used for statistical analysis. Results: The HER2/neu gene was amplification in 30% of the tumor samples. The statistical analysis showed a statistically significant relationship between HER2/neu gene amplification and progesterone receptors. Amplification of the HER2/neu gene significantly increases the chance of lymph node involvement. Also, the amplification of this gene in tumors with histological grade II tissue is more than grade I.
tags: Breast cancer · Gene amplification · HER2/neu oncogene · Prognostic factors